COTA expands clinicogenomics offering with Genomic Testing Cooperative partnership.
Achieving value in cancer care requires a
clinically detailed picture of your members’ journeys.
By providing a population-based view of a specific cancer’s care delivery, we enable the identification of unwarranted variation in care that may adversely impact quality, outcomes and cost. Armed with this information, you can design and implement effective value-based programs, including medical home models, bundled and episode payments, and shared-risk arrangements.
By combining clinical expertise and claims data, we can use our advanced classification system, the CNA, to more precisely analyze patient populations and manage spend.
Because your members deserve a data-driven approach that ensures they receive high-quality care in the right setting, when they need it most.
We can leverage your data to design realistic, rewarding models that advance collaboration with your oncology provider partners.
Our analysis of your data lets you look deeply at performance and outcomes across sites, service lines and even individual providers, so you can evaluate variation and take action to improve care quality and outcomes.
Our easy-to-use data visualization tools display your member data in the clearest, most impactful way to inform and track performance in value models.
Interested in learning more about how we can transform cancer care together?
